11 | CytokinesIBA
01/2022
-
01/2017 |
7 | InterleukinsIBA
05/2021
-
06/2018 |
6 | Interleukin-22 (IL-22)IBA
05/2021
-
01/2017 |
6 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
-
11/2016 |
4 | Interleukin-6 (Interleukin 6)IBA
01/2022
-
01/2017 |
4 | Interleukin-17 (Interleukin 17)IBA
05/2020
-
01/2017 |
4 | Biomarkers (Surrogate Marker)IBA
02/2020
-
09/2017 |
4 | Proteins (Proteins, Gene)FDA Link
01/2020
-
01/2017 |
3 | Pharmaceutical PreparationsIBA
01/2022
-
10/2018 |
3 | interleukin 20 (IL-20)IBA
12/2021
-
11/2020 |
3 | LipopolysaccharidesIBA
07/2021
-
01/2020 |
3 | LipidsIBA
07/2021
-
09/2020 |
3 | Messenger RNA (mRNA)IBA
06/2021
-
01/2017 |
3 | Interleukin-12 (IL 12)IBA
01/2020
-
01/2019 |
3 | Interleukin-12 Subunit p35IBA
01/2020
-
09/2018 |
3 | salicylhydroxamic acid (SHAM)IBA
01/2019
-
01/2017 |
3 | Brain Natriuretic Peptide (Natrecor)FDA Link
01/2019
-
01/2017 |
3 | Angiotensin IIIBA
01/2018
-
01/2017 |
2 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
01/2022
-
10/2021 |
2 | CalcineurinIBA
10/2021
-
10/2018 |
2 | resolvin D1IBA
01/2021
-
09/2020 |
2 | L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
-
10/2020 |
2 | MB Form Creatine KinaseIBA
10/2020
-
01/2017 |
2 | 5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
10/2020
-
01/2020 |
2 | Therapeutic UsesIBA
09/2020
-
01/2019 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2020
-
10/2018 |
2 | Interleukin-27 (Interleukin 27)IBA
01/2020
-
01/2020 |
2 | Interleukin-23 (Interleukin 23)IBA
01/2020
-
01/2020 |
2 | Biological ProductsIBA
01/2020
-
01/2017 |
2 | trimethyloxamine (trimethylamine N-oxide)IBA
06/2019
-
03/2018 |
2 | Interleukin-11 (Interleukin 11)IBA
01/2019
-
06/2018 |
2 | TRPA1 Cation ChannelIBA
01/2019
-
01/2018 |
2 | Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018
-
01/2017 |
2 | Atrial Natriuretic Factor (ANF)IBA
11/2018
-
10/2018 |
2 | AnkyrinsIBA
10/2018
-
01/2018 |
2 | Phosphotransferases (Kinase)IBA
02/2018
-
01/2017 |
2 | Thymidine KinaseIBA
01/2018
-
09/2002 |
2 | SestrinsIBA
09/2017
-
01/2017 |
1 | InflammasomesIBA
10/2021 |
1 | 7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
07/2021 |
1 | N 30IBA
06/2021 |
1 | Saline SolutionIBA
05/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
05/2021 |
1 | JNK Mitogen-Activated Protein KinasesIBA
05/2021 |
1 | Celecoxib (Celebrex)FDA Link
05/2021 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2021 |
1 | Antiviral Agents (Antivirals)IBA
01/2021 |
1 | CXC ChemokinesIBA
01/2021 |
1 | Creatine Kinase (Creatine Phosphokinase)IBA
01/2021 |
1 | oxidized low density lipoproteinIBA
01/2021 |